FDG-PET/CT in Evaluation and Prognostication of Primary Prostate Lymphoma

被引：9

作者：

Hodgson, Richard ^{[2
]}

Huang, Yi-Tung ^{[3
]}

Steinke, Karin ^{[2
]}

Kumar, Aravind S. Ravi ^{[1
,3
]}

机构：

[1] Royal Brisbane & Womens Hosp, Dept Nucl Med, Brisbane, Qld 4029, Australia

[2] Royal Brisbane & Womens Hosp, Dept Med Imaging, Brisbane, Qld 4029, Australia

[3] Queensland PET Serv, Brisbane, Qld 4029, Australia

来源：

CLINICAL NUCLEAR MEDICINE | 2010年 / 35卷 / 06期

关键词：

prostate; non-Hodgkin lymphoma; PET/CT; F-18; FDG; prognosis; NON-HODGKINS-LYMPHOMA; CARCINOMA; THERAPY;

D O I：

10.1097/RLU.0b013e3181db4eb7

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

A 76-year-old man was incidentally diagnosed with prostate lymphoma following transurethral resection of the prostate for prostatism. Staging F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) revealed markedly increased FDG uptake in the prostate, with no evidence of other disease. Following combination chemotherapy, restaging FDG-PET/CT demonstrated a complete metabolic response. The patient subsequently achieved prolonged remission on follow-up. Because of its rarity, FDG-PET in predicting outcome after therapy has not been validated for primary prostate lymphoma. This case highlights the potential of FDG-PET/CT in not only evaluation of disease extent but also prognostication of primary lymphoma of the prostate. Copyright © 2010 by Lippincott Williams & Wilkins.

引用

页码：418 / 420

页数：3

共 50 条

[31] Usefulness of FDG-PET in diagnosing primary lymphoma of the liver
Bangerter, M
Moog, F
Griesshammer, M
Merkle, E
Hafner, M
Ellenrieder, V
Reske, SN
Heimpel, H
INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 66 (04) : 517 - 520
[32] Detection of unexpected prostate cancer with FDG-PET/CT
Ishimori, Takayoshi
Ishibashi, Mana
Yamada, Tsuyoshi
Watanabe, Yuji
JOURNAL OF NUCLEAR MEDICINE, 2012, 53
[33] FDG-PET in staging primary gastrointestinal lymphoma.
Boeck, W
Froehlich, A
Roempp, A
Reske, SN
Lutz, MP
Adler, G
GASTROENTEROLOGY, 1998, 114 (04) : A566 - A566
[34] Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT
Ken Herrmann
Marcelo Queiroz
Martin W. Huellner
Felipe de Galiza Barbosa
Andreas Buck
Niklaus Schaefer
Paul Stolzman
Patrick Veit-Haibach
BMC Cancer, 15
[35] FDG-PET/CT in Primary Large B-Cell Lymphoma of the Hard Palate
Kalkanis, Dimitrios
Kalkani, Maria
Gomes, Hilton
Paes, Fabio
Sideras, Panagiotis
Sfakianakis, George N.
CLINICAL NUCLEAR MEDICINE, 2010, 35 (01) : 24 - 25
[36] FDG-PET/CT in the evaluation of anal carcinoma
Cotter, Shane E.
Grigsby, Perry W.
Siegel, Barry A.
Dehdashti, Farrokh
Malyapa, Robert S.
Fleshman, James W.
Birnbaum, Elisa H.
Wang, Xia
Abbey, Elliot
Tan, Benjamin
Kodner, Ira J.
Hunt, Steven R.
Lowney, Jennifer K.
Mutch, Matthew G.
Dietz, David W.
Myerson, Robert J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03): : 720 - 725
[37] Can FDG-PET/CT distinguish primary thyroid lymphoma from chronic thyroiditis?
Nakadate, M.
Yoshida, K.
Ishii, A.
Koizumi, M.
Ryu, Y.
Nakagawa, T.
Suzuki, Y.
Umehara, I.
Shibuya, H.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S99 - S99
[38] Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT
Herrmann, Ken
Queiroz, Marcelo
Huellner, Martin W.
Barbosa, Felipe de Galiza
Buck, Andreas
Schaefer, Niklaus
Stolzman, Paul
Veit-Haibach, Patrick
BMC CANCER, 2015, 15
[39] Primary Pancreatic Lymphoma on FDG PET/CT
Wang, Peipei
Cheng, Xin
Huo, Li
Li, Fang
CLINICAL NUCLEAR MEDICINE, 2020, 45 (10) : 830 - 832
[40] Weight loss as primary indication for FDG-PET/CT
Maliha, Peter George
Singerman, Julia
Probst, Stephan
NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (10) : 1066 - 1072

← 1 2 3 4 5 →